BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kolaczynska KE, Thomann J, Hoener MC, Liechti ME. The Pharmacological Profile of Second Generation Pyrovalerone Cathinones and Related Cathinone Derivative. Int J Mol Sci 2021;22:8277. [PMID: 34361040 DOI: 10.3390/ijms22158277] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Kuropka P, Zawadzki M, Szpot P. A narrative review of the neuropharmacology of synthetic cathinones-Popular alternatives to classical drugs of abuse. Hum Psychopharmacol 2023;:e2866. [PMID: 36866677 DOI: 10.1002/hup.2866] [Reference Citation Analysis]
2 Nadal-Gratacós N, Ríos-Rodríguez E, Pubill D, Batllori X, Camarasa J, Escubedo E, Berzosa X, López-Arnau R. Structure-Activity Relationship of N-Ethyl-Hexedrone Analogues: Role of the α-Carbon Side-Chain Length in the Mechanism of Action, Cytotoxicity, and Behavioral Effects in Mice. ACS Chem Neurosci 2023;14:787-99. [PMID: 36734852 DOI: 10.1021/acschemneuro.2c00772] [Reference Citation Analysis]
3 Miró Ò, Burillo-Putze G, Schmid Y, Salgado E, Liechti ME, Dines AM, Giraudon I, Heyerdahl F, Hovda KE, Vallersne OM, Eyer F, Wood DM, Yates C, Dargan PI, Galicia M; Euro-DEN Plus Research Group. Severity of emergency department presentations due to acute drug toxicity in Europe: a longitudinal analysis over a 6-year period (2014-2019) stratified by sex. Eur J Emerg Med 2023;30:21-31. [PMID: 36350710 DOI: 10.1097/MEJ.0000000000000978] [Reference Citation Analysis]
4 Kuropka P, Zawadzki M, Szpot P. A review of synthetic cathinones emerging in recent years (2019-2022). Forensic Toxicol 2023;41:25-46. [PMID: 36124107 DOI: 10.1007/s11419-022-00639-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Paškan M, Rimpelová S, Svobodová Pavlíčková V, Spálovská D, Setnička V, Kuchař M, Kohout M. 4-Isobutylmethcathinone-A Novel Synthetic Cathinone with High In Vitro Cytotoxicity and Strong Receptor Binding Preference of Enantiomers. Pharmaceuticals (Basel) 2022;15. [PMID: 36558946 DOI: 10.3390/ph15121495] [Reference Citation Analysis]
6 Busardò FP, Pichini S. Molecular Insights on New Psychoactive Substances (NPSs). Int J Mol Sci 2022;23:3282. [PMID: 35328703 DOI: 10.3390/ijms23063282] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Clauss NJ, Daws LC. Neurotransmitter Transporters and Their Role in the Pharmacological Actions of Therapeutic and Abused Drugs. Comprehensive Pharmacology 2022. [DOI: 10.1016/b978-0-12-820472-6.00172-9] [Reference Citation Analysis]
8 Sahai MA, Opacka-Juffry J. Molecular mechanisms of action of stimulant novel psychoactive substances that target the high-affinity transporter for dopamine. Neuronal Signal 2021;5:NS20210006. [PMID: 34888062 DOI: 10.1042/NS20210006] [Reference Citation Analysis]